Viridian Therapeutics, Inc.
VRDN
$28.68
$0.270.95%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 874.65M | 490.90M | 563.36M | 636.63M | 717.58M |
| Total Receivables | -- | 70.00M | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 19.58M | 11.01M | 15.39M | 20.61M | 20.88M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 894.23M | 571.91M | 578.75M | 657.24M | 738.46M |
|
|
|||||
| Total Current Assets | 894.23M | 571.91M | 578.75M | 657.24M | 738.46M |
| Net Property, Plant & Equipment | 3.65M | 3.71M | 3.07M | 3.25M | 3.44M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.54M | 1.52M | 506.00K | 489.00K | 501.00K |
| Total Assets | 899.42M | 577.14M | 582.32M | 660.98M | 742.40M |
|
|
|||||
| Total Accounts Payable | 8.68M | 10.06M | 8.52M | 3.89M | 2.14M |
| Total Accrued Expenses | 60.89M | 39.53M | 34.79M | 28.92M | 44.93M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 753.00K | 730.00K | 8.99M | 536.00K | 513.00K |
| Total Finance Division Other Current Liabilities | 367.00K | 372.00K | 288.00K | 388.00K | 288.00K |
| Total Other Current Liabilities | 367.00K | 372.00K | 288.00K | 388.00K | 288.00K |
| Total Current Liabilities | 70.70M | 50.70M | 52.59M | 33.73M | 47.87M |
|
|
|||||
| Total Current Liabilities | 70.70M | 50.70M | 52.59M | 33.73M | 47.87M |
| Long-Term Debt | 49.94M | 20.89M | 12.35M | 20.69M | 20.58M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.90M | 2.58M | 1.74M | 1.88M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 54.72M | -- | 477.00K | 212.00K | 2.31M |
| Total Liabilities | 177.25M | 74.17M | 67.16M | 56.51M | 70.76M |
|
|
|||||
| Common Stock & APIC | 1.93B | 1.53B | 1.51B | 1.50B | 1.48B |
| Retained Earnings | -1.34B | -1.22B | -1.18B | -1.08B | -995.86M |
| Treasury Stock & Other | 447.00K | 363.00K | 69.00K | 245.00K | -10.00K |
| Total Common Equity | 590.11M | 314.09M | 326.28M | 415.59M | 482.75M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 132.06M | 188.89M | 188.89M | 188.89M | 188.89M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 132.06M | 188.89M | 188.89M | 188.89M | 188.89M |
|
|
|||||
| Total Common Equity | 590.11M | 314.09M | 326.28M | 415.59M | 482.75M |
| Total Preferred Equity | 132.06M | 188.89M | 188.89M | 188.89M | 188.89M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 722.17M | 502.97M | 515.17M | 604.47M | 671.64M |
|
|
|||||